Jul. 2, 2020—The university remains in phase 2 of its Vanderbilt Return to Campus Plan as the city of Nashville reverted to phase 2 of its Roadmap to Reopening Nashville Plan with modifications late last week. Vanderbilt moved to Phase 2 of its Return to Campus Plan on June 8.
Jul. 1, 2020—In a wide-ranging interview, Chancellor Daniel Diermeier discusses growing up as a first-generation student in a divided Germany, taking the helm during the COVID-19 pandemic, and the collaborative culture that has fueled Vanderbilt’s success.
Jun. 29, 2020—Being a biomedical scientist has served Interim Chancellor and Provost Susan R. Wente well as she’s led the university through “a rapid succession of significant decisions” since the first reports of COVID-19.
Vanderbilt medical experts discuss health disparities, inequities during COVID-19 on webinar co-hosted with SEC chief diversity officers
Jun. 26, 2020—More than 600 attendees from across the Southeast participated in a June 24 webinar on COVID-19 health disparities hosted by Vanderbilt and presented by the chief diversity officers of universities in the Southeastern Conference.
Jun. 24, 2020—The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19.
Data Science Institute big data model to help Monroe Carell Jr. Children’s Hospital prepare for patient needs during pandemic and beyond
Jun. 24, 2020—Vanderbilt's Data Science Institute researchers are developing a model to use big data to address the impact of COVID-19 on policies, procedures, and resources now and in the future. The tool will help Monroe Carell Jr. Children's Hospital at Vanderbilt evaluate short- and long-term resource needs in order to be fully prepared to meet patients' needs.
Jun. 24, 2020—Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
Jun. 22, 2020—Interim Chancellor and Provost Susan R. Wente and Dr. Jeff Balser, president and CEO of Vanderbilt University Medical Center and dean of the School of Medicine, discuss VUMC’s efforts on the frontlines of the COVID-19 pandemic—both the search for treatments and a vaccine, and providing world-class patient care.
Jun. 22, 2020—While Nashville will enter the third phase of its Roadmap for Reopening beginning Monday, June 22, Vanderbilt University will continue to follow its own Return to Campus Plan, which is currently in Vanderbilt Phase 2.
Jun. 21, 2020—The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.
Jun. 19, 2020—Vanderbilt University is making substantial investments in classroom technology to support faculty as the fall semester approaches. The strategy includes upgrading classroom technology to support livestreaming and recording in classrooms, building new video recording studios, and training faculty in both new and existing technology available in the classroom.
Jun. 18, 2020—Karl Zelik, assistant professor of mechanical and biomedical engineering, discusses how wearable technology can help reduce injuries and assist workers at the frontline of COVID-19.